Celcuity (CELC) Competitors $13.16 +0.40 (+3.13%) Closing price 04:00 PM EasternExtended Trading$13.16 +0.00 (+0.04%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CELC vs. NHC, VRDN, AGL, FTRE, CDNA, AHCO, GRAL, AVAH, PNTG, and CSTLShould you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include National HealthCare (NHC), Viridian Therapeutics (VRDN), agilon health (AGL), Fortrea (FTRE), CareDx (CDNA), AdaptHealth (AHCO), Grail (GRAL), Aveanna Healthcare (AVAH), The Pennant Group (PNTG), and Castle Biosciences (CSTL). These companies are all part of the "healthcare" industry. Celcuity vs. National HealthCare Viridian Therapeutics agilon health Fortrea CareDx AdaptHealth Grail Aveanna Healthcare The Pennant Group Castle Biosciences National HealthCare (NYSE:NHC) and Celcuity (NASDAQ:CELC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, community ranking, risk and earnings. Which has more risk and volatility, NHC or CELC? National HealthCare has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Does the media prefer NHC or CELC? In the previous week, National HealthCare had 3 more articles in the media than Celcuity. MarketBeat recorded 4 mentions for National HealthCare and 1 mentions for Celcuity. Celcuity's average media sentiment score of 0.68 beat National HealthCare's score of 0.17 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National HealthCare 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Celcuity 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of NHC or CELC? 56.4% of National HealthCare shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 13.8% of National HealthCare shares are held by company insiders. Comparatively, 15.8% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has higher earnings & valuation, NHC or CELC? National HealthCare has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational HealthCare$1.14B1.37$66.80M$7.9812.71CelcuityN/AN/A-$63.78M-$2.61-4.97 Is NHC or CELC more profitable? National HealthCare has a net margin of 10.03% compared to Celcuity's net margin of 0.00%. National HealthCare's return on equity of 6.87% beat Celcuity's return on equity.Company Net Margins Return on Equity Return on Assets National HealthCare10.03% 6.87% 4.68% Celcuity N/A -62.66%-39.78% Do analysts rate NHC or CELC? Celcuity has a consensus target price of $30.17, indicating a potential upside of 132.61%. Given Celcuity's stronger consensus rating and higher possible upside, analysts clearly believe Celcuity is more favorable than National HealthCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National HealthCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Celcuity 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Does the MarketBeat Community prefer NHC or CELC? Celcuity received 336 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 67.60% of users gave Celcuity an outperform vote. CompanyUnderperformOutperformNational HealthCareOutperform Votes2100.00% Underperform VotesNo VotesCelcuityOutperform Votes33867.60% Underperform Votes16232.40% SummaryNational HealthCare and Celcuity tied by winning 9 of the 18 factors compared between the two stocks. Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELC vs. The Competition Export to ExcelMetricCelcuityMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$480.83M$3.23B$5.82B$9.18BDividend YieldN/A19.55%5.25%3.99%P/E Ratio-4.9615.9824.8119.27Price / SalesN/A173.19465.4979.23Price / CashN/A378.2844.6537.93Price / Book2.375.257.635.18Net Income-$63.78M-$22.21M$3.19B$245.95M7 Day Performance4.50%3.50%1.18%1.70%1 Month Performance18.66%8.39%3.21%1.19%1 Year Performance-14.90%17.40%20.06%15.79% Celcuity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELCCelcuity2.1109 of 5 stars$13.16+3.1%$30.17+129.2%-16.3%$488.63MN/A-5.0440Short Interest ↑NHCNational HealthCareN/A$100.71+1.0%N/AN/A$1.55B$1.14B12.6213,123Dividend AnnouncementNews CoverageVRDNViridian Therapeutics2.9499 of 5 stars$17.98+1.2%$35.70+98.6%-14.7%$1.42B$310,000.00-4.1750News CoverageAGLagilon health1.5939 of 5 stars$3.29-1.4%$4.03+22.6%-51.5%$1.35B$4.32B-3.491,117Upcoming EarningsNews CoverageFTREFortrea2.3792 of 5 stars$15.07+1.1%$23.30+54.6%-57.3%$1.35B$3.11B-4.4118,000CDNACareDx3.0711 of 5 stars$24.91+11.2%$28.33+13.7%+201.2%$1.34B$312.78M-9.23740Upcoming EarningsAnalyst DowngradeHigh Trading VolumeAHCOAdaptHealth3.4564 of 5 stars$9.16-1.8%$12.40+35.4%+16.5%$1.23B$3.20B-5.5510,700GRALGrail1.0579 of 5 stars$33.37+3.6%$16.00-52.1%N/A$1.12BN/A0.001,360Short Interest ↓AVAHAveanna Healthcare0.683 of 5 stars$4.76+1.9%$4.51-5.2%+107.9%$919.78M$1.90B-14.0033,500News CoveragePNTGThe Pennant Group3.7717 of 5 stars$26.68+0.3%$36.00+34.9%+65.4%$916.46M$544.89M39.245,791Upcoming EarningsPositive NewsCSTLCastle Biosciences2.071 of 5 stars$27.71+0.4%$40.29+45.4%+5.6%$776.16M$219.79M138.56540 Related Companies and Tools Related Companies National HealthCare Competitors Viridian Therapeutics Competitors agilon health Competitors Fortrea Competitors CareDx Competitors AdaptHealth Competitors Grail Competitors Aveanna Healthcare Competitors The Pennant Group Competitors Castle Biosciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CELC) was last updated on 2/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.